Bacil Pharma Ltd — Insider Trading, 25-06-2026: Insider Trading / SAST

The company has announced the closure of its trading window for Designated Persons, effective July 1st. This is a standard procedure ahead of the Board Meeting scheduled to consider the financial results for the quarter ending June 30th. The trading window will remain closed until 48 hours after this Board Meeting concludes. Shareholders should note that the specific date for the Board Meeting will be communicated independently. This practice ensures transparency and prevents insider trading activities.